President Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S., but not immediately ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

When female athletes collapse on the playing field, they are less likely to be resuscitated than men: How gender differences ...

The centerpiece of the acquisition is Ohtuvayre, a treatment for chronic obstructive pulmonary disease that secured U.S. approval last year. The drug’s commercial launch has exceeded Wall Street ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The passage of President Trump's signature tax cut bill shows how the health care industry's influence is waning.

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Hype around a Microsoft AI agent's ability to diagnose difficult cases misses the mark and overlooks real innovation, experts ...

The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s work, current ...

Six major medical groups, and a pregnant physician, are suing HHS Secretary Robert F. Kennedy Jr. over changes he made to ...